Equity

Key Financial Ratios Home > Equity > Corporate Information > Key Financial Ratios

Novelix Pharmaceuticals LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:536565 P/E (TTM) :102.05
ISIN Demat:INE314I01036 Div & Yield %:0 EPS (TTM) :0.6
Book Value (RS) :17.9242922 Market Cap (Rs Cr.):98.83 Face Value (RS) :10
    Change Company 
YearsMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Debt-Equity Ratio0.000.000.000.000.00
Long Term Debt-Equity Ratio0.000.000.000.000.00
Current Ratio3.21106.13128.43315.33214.00
Fixed Assets36.572.970.830.600.85
Inventory30.274.202.843.567.94
Debtors3.3942.2013.2414.6315.41
Interest Cover Ratio0.000.000.000.000.00
PBIDTM (%)0.521.420.00-107.19-243.51
PBITM (%)0.390.47-3.13-112.23-249.62
PBDTM (%)0.521.420.00-107.19-243.51
CPM (%)0.391.180.00-107.19-243.51
APATM (%)0.260.24-3.13-112.23-249.62
ROCE (%)0.840.240.000.000.00
RONW (%)0.560.120.000.000.00

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)